Abscopal Effect of Radiotherapy and Nivolumab in Relapsed or Refractory Hodgkin Lymphoma (AERN): An International Multicenter Single-Arm Two-Stage Phase II GHSG Trial

被引：4

作者：

Broeckelmann, Paul J. ^{[1
,2
]}

Pluetschow, Annette ^{[1
,2
]}

Greil, Richard ^{[3
,4
,5
]}

Zijlstra, Josee M. ^{[6
]}

Illidge, Timothy ^{[7
]}

Fossa, Alexander ^{[8
,9
]}

Meissner, Julia ^{[10
,11
]}

Zimmermann, Andreas ^{[12
]}

Mathas, Stephan ^{[13
]}

Thol, Felicitas ^{[14
]}

Fuchs, Michael ^{[1
,2
]}

Engert, Andreas ^{[1
,2
]}

Baues, Christian ^{[15
,16
]}

机构：

[1] Univ Cologne, German Hodgkin Study Grp, Cologne, Germany

[2] Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Cologne, Germany

[3] Paracelsus Med Univ, Med Dept Hematol 3, Med Oncol Rheumatol & Infectiol, Salzburg, Austria

[4] Salzburg Canc Res Inst, Ctr Clin Canc & Immunol Trials, Salzburg, Austria

[5] Canc Cluster Salzburg, Salzburg, Austria

[6] Vrije Univ Amsterdam, Dept Hematol, Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands

[7] Univ Manchester, Manchester Acad Hlth Sci, Natl Inst Hlth & Res,Biomed Res Ctr,Fac Biol Med, Christie Hosp Natl Hlth Serv Fdn Trust,Div Canc S, Manchester, Lancs, England

[8] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway

[9] Oslo Univ Hosp, Oslo, Norway

[10] Heidelberg Univ, Med 5, Heidelberg, Germany

[11] Univ Heidelberg Hosp, Dept Internal Med 5, Heidelberg, Germany

[12] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Hematol Oncol, Munich, Germany

[13] Charite Univ Med Berlin, Hematol Oncol & Tumor Immunol, Berlin, Germany

[14] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, NH, Germany

[15] Univ Hosp Cologne, Fac Med, Dept Radiooncol & Cyberknife Ctr, Cologne, Germany

[16] Univ Hosp Cologne, Cologne, Germany

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124351

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1547

引用

页数：4

共 50 条

[21] Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial
Piccirillo, Maria Carmela
Avallone, Antonio
Carlomagno, Chiara
Maiello, Evaristo
Rosati, Gerardo
Alabiso, Oscar
Nasti, Guglielmo
De Placido, Sabino
Latiano, Tizana Pia
Bilancia, Domenico
Ottaiano, Alessandro
De Stefano, Alfonso
Romano, Carmela
Silvestro, Lucrezia
Nappi, Anna
Cassata, Antonino
Giordano, Pasqualina
Iaffaioli, Rosario Vincenzo
Normanno, Nicola
Perrone, Francesco
Daniele, Bruno
CLINICAL COLORECTAL CANCER, 2020, 19 (04) : 270 - 276
[22] Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study
Song, Yuqin
Gao, Quanli
Zhang, Huilai
Fan, Lei
Zhou, Jianfeng
Zou, Dehui
Li, Wei
Yang, Haiyan
Liu, Ting
Wang, Quanshun
Lv, Fangfang
Guo, Haiyi
Yang, Liudi
Elstrom, Rebecca
Huang, Jane
Novotny, William
Wei, Vivian
Zhu, Jun
LEUKEMIA, 2020, 34 (02) : 533 - 542
[23] Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study.
Su, Hang
Song, Yongping
Jiang, Wenqi
Sun, Xiuhua
Qian, Wenbin
Zhang, Wei
Gao, Yuhuan
Jin, Zhengming
Zhou, Jianfeng
Jin, Chuan
Zou, Liqun
Qiu, Lugui
Li, Wei
Yang, Jianmin
Hou, Ming
Zeng, Shan
Liu, Peng
Shi, Yuankai
Zhou, Hui
Wang, Shuyan
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[24] Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma
Song, Yuqin
Guo, Ye
Huang, Huiqiang
Li, Wei
Ke, Xiaoyan
Feng, Jifeng
Xu, Wei
Miao, Harry
Kinley, Judith
Song, Gregory
Dai, Yi
Wang, Hui
Zhu, Jun
EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 867 - 875
[25] Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial
Ding, Kaiyang
Liu, Hailing
Ma, Jie
Yang, Haiyan
Cao, Lei
Wang, Huihan
Peng, Hongling
Shi, Wei
Zhao, Xiaoli
Wu, Wei
Zhu, Huayuan
Li, Jianyong
Fan, Lei
HAEMATOLOGICA, 2023, 108 (08) : 2146 - 2154
[26] Sintilimab for Relapsed/Refractory Extranodal NK/T Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial (ORIENT-4)
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 19 - 20
[27] Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4)
Tao, Rong
Fan, Lei
Song, Yongping
Hu, Yu
Zhang, Wei
Wang, Yafei
Xu, Wei
Li, Jianyong
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[28] Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4)
Rong Tao
Lei Fan
Yongping Song
Yu Hu
Wei Zhang
Yafei Wang
Wei Xu
Jianyong Li
Signal Transduction and Targeted Therapy, 6
[29] Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
Younes, Anas
Oki, Yasuhiro
Bociek, R. Gregory
Kuruvilla, John
Fanale, Michelle
Neelapu, Sattva
Copeland, Amanda
Buglio, Daniela
Galal, Ahmed
Besterman, Jeffrey
Li, Zuomei
Drouin, Michel
Patterson, Tracy
Ward, M. Renee
Paulus, Jessica K.
Ji, Yuan
Medeiros, L. Jeffrey
Martell, Robert E.
LANCET ONCOLOGY, 2011, 12 (13): : 1222 - 1228
[30] Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Jacobson, Caron A.
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Munshi, Pashna N.
Casulo, Carla
Maloney, David G.
de Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry Chi Hang
Rosenblatt, Joseph
Rossi, John M.
Goyal, Lovely
Plaks, Vicki
Yang, Yin
Vezan, Remus
Avanzi, Mauro P.
Neelapu, Sattva S.
LANCET ONCOLOGY, 2022, 23 (01): : 91 - 103

← 1 2 3 4 5 →